PURE Bioscience

    OverviewSuggest Edit

    PURE Bioscience is a company developing and commercializing antimicrobial products. It develops a technology platform based on stabilized ionic silver and products containing silver dihydrogen citrate (SDC). In addition, the Company manufactures and distributes SDC-based disinfecting and sanitizing products. It produces and supplies SDC-based formulations for the production of personal care products.

    TypePublic
    Founded1992
    HQEl Cajon, USMap
    Websitepurebio.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Oct 2018)9(-10%)

    Key People/Management at PURE Bioscience

    Hank Lambert

    Hank Lambert

    CEO
    Mark Elliott

    Mark Elliott

    Vice President, Finance
    Tom Myers

    Tom Myers

    COO
    Dolana Blount

    Dolana Blount

    Vice President, Technology Development and Regulatory Affairs
    Bridget C. Tinsley-Cormier

    Bridget C. Tinsley-Cormier

    Vice President, Market Development
    Show more

    PURE Bioscience Office Locations

    PURE Bioscience has an office in El Cajon
    El Cajon, US (HQ)
    1725 Gillespie Way
    Show all (1)

    PURE Bioscience Financials and Metrics

    PURE Bioscience Revenue

    USD

    Net income (Q3, 2019)

    		(1.9m)

    EBIT (Q3, 2019)

    		(912.0k)

    Cash (30-Apr-2019)

    		340.0k
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cost of goods sold

    		565.0k344.0k285.0k441.0k760.0k763.0k

    General and administrative expense

    		5.7m5.1m4.9m5.1m5.2m5.2m

    R&D expense

    		1.3m1.0m790.0k927.0k779.0k459.0k

    Operating expense total

    		7.0m12.5m8.4m8.3m7.8m8.8m
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

    Cost of goods sold

    		36.0k20.0k89.0k45.0k111.0k65.0k54.0k48.0k116.0k265.0k134.0k132.0k146.0k161.0k166.0k203.0k160.0k117.0k

    General and administrative expense

    		993.0k1.2m1.3m1.2m1.2m1.2m1.1m1.4m1.4m1.3m1.3m1.3m1.4m1.4m1.2m1.1m1.0m886.0k

    R&D expense

    		234.0k289.0k248.0k176.0k215.0k171.0k236.0k238.0k205.0k248.0k214.0k222.0k144.0k120.0k117.0k97.0k67.0k85.0k

    Operating expense total

    		3.9m3.3m2.4m2.0m1.4m1.4m2.0m2.4m1.9m2.1m1.9m1.9m2.4m2.4m2.1m3.2m1.7m1.2m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    		32.0k86.0k1.3m5.2m1.6m851.0k

    Accounts Receivable

    		18.0k47.0k189.0k263.0k297.0k275.0k

    Inventories

    		249.0k207.0k350.0k273.0k197.0k

    Current Assets

    		486.0k478.0k2.0m6.1m2.5m1.5m
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

    Cash

    		1.1m236.0k416.0k5.3m3.9m2.5m6.1m6.7m5.4m4.1m3.9m2.7m3.2m2.1m1.0m776.0k335.0k340.0k

    Accounts Receivable

    		31.0k9.0k34.0k47.0k40.0k86.0k93.0k106.0k68.0k146.0k142.0k185.0k143.0k146.0k192.0k353.0k129.0k134.0k

    Inventories

    		430.0k429.0k387.0k231.0k186.0k207.0k219.0k237.0k320.0k348.0k340.0k348.0k274.0k267.0k275.0k209.0k205.0k195.0k

    Current Assets

    		1.8m895.0k1.0m5.8m4.2m2.9m6.6m7.2m6.2m5.0m4.6m3.5m3.9m2.7m1.6m1.5m793.0k772.0k
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    		(7.7m)(11.0m)(7.6m)(14.4m)(6.3m)(7.4m)

    Depreciation and Amortization

    		311.0k248.0k206.0k219.0k276.0k285.0k

    Inventories

    		149.0k(12.0k)42.0k(143.0k)27.0k37.0k

    Accounts Payable

    		(96.0k)(955.0k)(131.0k)(59.0k)103.0k
    Quarterly
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

    Net Income

    		(3.8m)(6.3m)(8.4m)(1.9m)(1.7m)(2.1m)(2.8m)(13.7m)(13.7m)(1.7m)(2.7m)(4.4m)(2.3m)(4.4m)(6.1m)(2.6m)(3.9m)(5.7m)

    Depreciation and Amortization

    		73.0k140.0k196.0k51.0k51.0k103.0k154.0k65.0k134.0k204.0k71.0k142.0k213.0k71.0k143.0k191.0k

    Inventories

    		(65.0k)(64.0k)(22.0k)18.0k(12.0k)(30.0k)(113.0k)2.0k10.0k2.0k(1.0k)(20.0k)17.0k(12.0k)(8.0k)2.0k

    Accounts Payable

    		42.0k(275.0k)(588.0k)(955.0k)510.0k533.0k(250.0k)(33.0k)(125.0k)147.0k(36.0k)58.0k(38.0k)7.0k(52.0k)(206.0k)(128.0k)(255.0k)
    show all
    USDY, 2019

    Financial Leverage

    		1.4 x
    Show all financial metrics

    PURE Bioscience Online and Social Media Presence

    PURE Bioscience's Trends

    Embed Graph

    PURE Bioscience News and Updates

    June 13, 2018

    PURE Bioscience, Inc. (PURE) CEO Hank Lambert on Q3 2018 Results - Earnings Call Transcript

     PURE Bioscience Frequently Asked Questions

    • When was PURE Bioscience founded?

      PURE Bioscience was founded in 1992.

    • Who are PURE Bioscience key executives?

      PURE Bioscience's key executives are Hank Lambert, Mark Elliott and Tom Myers.

    • How many employees does PURE Bioscience have?

      PURE Bioscience has 9 employees.

    • Who are PURE Bioscience competitors?

      Competitors of PURE Bioscience include Biosan Laboratories, 2XL and Peptilogics.

    • Where is PURE Bioscience headquarters?

      PURE Bioscience headquarters is located at 1725 Gillespie Way, El Cajon.

    • Where are PURE Bioscience offices?

      PURE Bioscience has an office in El Cajon.

    • How many offices does PURE Bioscience have?

      PURE Bioscience has 1 office.